Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Cytokine/chemokine dysregulation in progressive MS patient is apparent and can be modulated by calpain inhibition.

Polcyn R, Capone M, Matzelle D, Lueking B, Walker A, Kau E, Haque A, Banik N.

Metab Brain Dis. 2019 Dec 18. doi: 10.1007/s11011-019-00521-1. [Epub ahead of print]

PMID:
31853829
2.

A Missing Link between Neuron Specific Enolase Release and Poor Prognosis in Aging Patients with B-cell Lymphoma.

Polcyn R, God J, Capone M, Matzelle D, Banik NL, Haque A.

J Clin Cell Immunol. 2018;9(3). pii: e121. doi: 10.4172/2155-9899.1000e121. Epub 2018 May 15. No abstract available.

3.

Distinct Cytokine and Chemokine Expression in Plasma and Calpeptin-Treated PBMCs of a Relapsing-Remitting Multiple Sclerosis Patient: A Case Report.

Chandran R, Capone M, Matzelle D, Polcyn R, Kau E, Haque A, Banik NL.

Neurochem Res. 2018 Dec;43(12):2224-2231. doi: 10.1007/s11064-018-2655-z. Epub 2018 Oct 5.

PMID:
30291537
4.

New Insights into the Role of Neuron-Specific Enolase in Neuro-Inflammation, Neurodegeneration, and Neuroprotection.

Haque A, Polcyn R, Matzelle D, Banik NL.

Brain Sci. 2018 Feb 18;8(2). pii: E33. doi: 10.3390/brainsci8020033. Review.

5.

Neuron specific enolase is a potential target for regulating neuronal cell survival and death: implications in neurodegeneration and regeneration.

Polcyn R, Capone M, Hossain A, Matzelle D, Banik NL, Haque A.

Neuroimmunol Neuroinflamm. 2017;4:254-257. doi: 10.20517/2347-8659.2017.59. Epub 2017 Dec 6. No abstract available.

6.

Enolase and Acute Spinal Cord Injury.

Polcyn R, Capone M, Hossain A, Matzelle D, Banik NL, Haque A.

J Clin Cell Immunol. 2017;8(6). pii: 536. doi: 10.4172/2155-9899.1000536. Epub 2017 Dec 29. No abstract available.

Supplemental Content

Loading ...
Support Center